Neurosciences Research

At Houston Methodist, our teams are dedicated to the development of new treatments and therapies for such neurological challenges as stroke, Parkinson’s disease, Alzheimer’s disease, amyotrophic lateral sclerosis (ALS), myasthenia gravis, brain tumors, concussion, spinal disorders, brain aneurysms, arteriovenous malformations, moyamoya disease, stuttering, Tourette’s syndrome and chronic inflammatory demyelinating polyneuropathy (CIDP). 

We concentrate our investigations on meaningful translational research that broadens our understanding of the major neurological challenges of brain, pituitary tumors, brain microcirculation in normal and pathological conditions, neurodegenerative and neuromuscular diseases, computational hemodynamics (simulating blood flow in cerebral aneurysms), functional magnetic resonance imaging, speech disorder and developmental learning disability modeling.

Immune Cells Hold Promise in Slowing Down ALS

A Houston Methodist study showed promising results for patients with ALS, also know as Lou Gehrig's disease.
Watch video >

Virtual Reality Makes Surgery Safer for Patients

Gavin Britz, MBBCh, MPH, MBA, describes how virtual reality is helping him better plan neurosurgery procedures and leading to safer surgeries. Learn more


At Houston Methodist, we’re studying proteins in the brain and genes, to better understand how we can prevent, slow—and one day stop— Alzheimer’s. We’re transforming the way we approach it, so future generations can live without it. Learn more.

Neurosciences Director

Tetsuo Ashizawa

Tetsuo Ashizawa, MD, director of the  Neuroscience Research Program 
Faculty Profile | Clinical Profile